Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tick-borne Encephalitis Virus Envelope Glycoprotein
- Molecular classification
- Viral protein, Envelope glycoprotein
01
Overview
The envelope glycoprotein (E protein) of the tick-borne encephalitis virus (TBEV) is the major surface protein and a critical component of the mature virion. It plays essential roles in viral entry, membrane fusion, receptor binding, and induction of protective immunity. The E glycoprotein consists of 496 amino acid residues organized into four domains: Domain I (central β-barrel), Domain II (elongated/fusion loop/dimerization interface), Domain III (Ig-like fold), and the Stem-anchor region. It is glycosylated at Asn154. The E protein mediates attachment to host cell receptors and triggers low-pH-induced fusion between viral and endosomal membranes. It undergoes conformational changes ("virus breathing") influencing antibody accessibility and is a major target for neutralizing antibodies.
02
Mechanism of action
Viral entry inhibition (potential target for antivirals)
03
Biological functions
Receptor bindingMembrane fusionViral entryInduction of protective immunity
04
Disease associations
InfectionTick-borne encephalitis
05
Safety considerations
Potential for off-target effects if targeting conserved regionsRisk of resistance development
Beyond the preview
Go deeper on Tick-borne Encephalitis Virus Envelope Glycoprotein.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tick-borne Encephalitis Virus Envelope Glycoprotein.